The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils

Paola Rogliani (Rome, Italy), Paola Rogliani, Ermanno Puxeddu, Chiara Ciaprini, Gabriella Pezzuto, Luigino Calzetta, Mario Cazzola

Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Session: Biomarkers and phenotypes of COPD
Session type: Thematic Poster
Number: 3663
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paola Rogliani (Rome, Italy), Paola Rogliani, Ermanno Puxeddu, Chiara Ciaprini, Gabriella Pezzuto, Luigino Calzetta, Mario Cazzola. The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils. Eur Respir J 2016; 48: Suppl. 60, 3663

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016



Do all COPD patients present irreversible airflow limitation?
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013

COPD: problems in diagnosis and measurement
Source: Eur Respir J 2003; 21: 4S-12S
Year: 2003



Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


Spirometry screening in the community: is this an effective way of diagnosing early COPD?
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005


Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Study assoicção between severity stages of chronic obstructive pulmonary disease and fasting glucose in patients with this disease
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013

The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016

Increased circulating fibrocytes associated with lung function decline in COPD patients with desaturation during 6 minute walk test
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015

Application of impulse oscillometry and bronchial dilation test for analysis in patients with asthma and chronic obstructive pulmonary disease
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Scintigraphic parameters in COPD patients
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013

COPD patients with exertional desaturation have a higher risk of rapid lung function decline
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013

Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016


Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015